Clinical Trial Update: Bronchial Artery Infusion of Gemcitabine in Treating Patients With Recurrent or Progressive Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

The document reports a Phase 1 trial evaluating bronchial artery infusion of gemcitabine for recurrent or progressive non-small cell lung cancer, which was term…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gemzar (gemcitabine)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Lung Cancer | Phase 1 | Status: TERMINATED